IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

about

Insulin-Like Growth Factor (IGF) System in Liver Diseases.Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms

P2860

Q52558393-D72F8C40-7B74-4479-A379-818A6F4E4C1E Q58122029-C38435DF-8B4C-422A-8236-EB5F452A1357

P2860

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

Item

http://www.wikidata.org/entity/Q47777518

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

@en

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

@nl

type

Item

label

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

@en

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

@nl

prefLabel

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

@en

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

@nl

P1476

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

@en

P2093

Hannes Hagström

http://www.w3.org/2001/XMLSchema#string

Ishrath Ansurudeen

http://www.w3.org/2001/XMLSchema#string

Kerstin Brismar

http://www.w3.org/2001/XMLSchema#string

Per Stål

http://www.w3.org/2001/XMLSchema#string

Rolf Hultcrantz

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines on the use of liver biopsy in clinical practice

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease.

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

Phosphorylated IGFBP-1 as a non-invasive predictor of liver fat in NAFLD.

Regulation and action of insulin-like growth factors at the cellular level.

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

Insulin-like growth factor-I and the liver.

P304

1427-1434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365521.2017.1379556

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28927302

http://www.w3.org/2001/XMLSchema#string

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

about

P2860

P2860

IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698